The facility will be located in Montgomery County, Pennsylvania, and Johnson & Johnson said the move will expand its U.S.\u00a0manufacturing capacity<\/a> along with its pipeline of transformational medicines for cancer, immune-mediated and neurological diseases.<\/p>\n Johnson & Johnson added that the facility will have cutting-edge manufacturing processes and support over 500 skilled biomanufacturing jobs once its fully operational, as well as over 4,000 construction jobs during its construction.<\/p>\n “For 140 years, Johnson & Johnson has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,” said Johnson & Johnson CEO Joaquin Duato.\u00a0<\/p>\n JOHNSON & JOHNSON INVESTING $2B IN US MANUFACTURING, CREATING NEW JOBS<\/a><\/p>\n Johnson & Johnson announced plans to invest $1 billion in a new gene therapy manufacturing facility in Pennsylvania. (Cristina Arias\/Cover\/Getty Images)<\/p>\n “By uniting scientific excellence with state-of-the-art manufacturing and strategic investment, and by working collaboratively with our communities, we are delivering for patients and creating significant opportunities for workers and families,” Duato added.<\/p>\n The $1 billion investment in the new cell therapy manufacturing facility comes as part of the company’s previously announced plan to\u00a0invest $55 billion<\/a> in manufacturing, research and development, and technology in the U.S. through early 2029.<\/p>\n OBAMACARE ENROLLMENT FELL BY MORE THAN 1M ENROLLEES FOR 2026<\/a><\/p>\n Ticker Security Last Change Change % JNJ<\/a> JOHNSON & JOHNSON 245.50 +0.57 Johnson & Johnson noted that the facility will deepen its presence in\u00a0Pennsylvania<\/a>, which it said has an economic impact of about $10 billion annually.<\/p>\n The company has 10 facilities covering over 2 million square feet in the Keystone State. Johnson & Johnson has manufacturing, research, distribution and office operations in Pennsylvania.<\/p>\n PRESIDENT LAUNCHES TRUMPRX.GOV WEBSITE OFFERING AMERICANS DISCOUNTED PRESCRIPTION DRUG PRICES: ‘HISTORIC’<\/a><\/p>\n Johnson & Johnson’s investment is part of a previously announced $55 billion commitment. (Courtesy of Johnson & Johnson)<\/p>\n Pennsylvania Gov.\u00a0Josh Shapiro<\/a>, a Democrat, said that the announcement shows the state is a “powerhouse for innovation and manufacturing in the life sciences” and added that the Johnson & Johnson announcement shows that companies “know we’ve got the strategy, the workforce, and the speed they need to succeed.”<\/p>\n “Pennsylvania leads in life sciences and advanced manufacturing because we consistently deliver what companies like Johnson & Johnson need to succeed: a skilled workforce, premier research institutions, and proven manufacturing strength,” said Sen.\u00a0Dave McCormick<\/a>, R-Pa. “This $1 billion-plus investment in a new Lower Gwynedd facility is a testament to that leadership and will produce life-changing treatments for patients, along with new and good jobs for our Commonwealth.”<\/p>\n![\"Johnson](\"https:\/\/www.newsbeep.com\/us-pa\/wp-content\/uploads\/2026\/02\/johnson-and-johnson-building-2.jpg\")
<\/p>\n
\n +0.23%<\/p>\n![\"New](\"https:\/\/www.newsbeep.com\/us-pa\/wp-content\/uploads\/2026\/02\/Johnson-Johnson-New-Logo.jpg\"){kind=logo}
<\/p>\n